Latest News
Own Starbucks by Nov. 13 to Qualify for Its Nov. 27 Dividend. Here's How Many Shares You'd Need for $500 in Yearly Dividends.fool.com
Starbucks may finally be turning the corner after years of lackluster returns.
Via The Motley Fool · October 22, 2026
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatilityfool.com
Bristol Myers Squibb has led in seven of eight quarters, but Novo Nordisk's recent spike signals a shift worth watching for income-focused investors.
Via The Motley Fool · October 22, 2026
Are RTX Corporation and Northrop Grumman Ready to Break Out?marketbeat.com
RTX and Northrop Grumman posted record Q3 backlogs, raised guidance, and strengthened balance sheets, pointing to long-term growth despite margin pressures and paused buybacks.
Via MarketBeat · October 22, 2026
Midterm Elections Are Shaping Up as a Worst-Case Scenario for the Stock Market, but This Isn't the Full Storyfool.com
History says that investors should be prepared for subpar stock market returns.
Via The Motley Fool · October 22, 2026
Comcast’s (NASDAQ:CMCSA) Q3 2026 earnings results: revenue in line with expectations
Telecommunications and media company Comcast (NASDAQ:CMCSA) met Wall Street’s revenue expectations in Q3 2026, but sales were flat year on year at $29.3 bill...
Via StockStory · October 22, 2026
Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?fool.com
Eli Lilly's revenue nearly doubled over two years while Bristol Myers Squibb remained relatively flat, widening the gap between these two pharma giants.
Via The Motley Fool · October 22, 2026
Quest’s (NYSE:DGX) Q3 2026: beats on revenue
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 10% year on year t...
Via StockStory · October 22, 2026
Tractor Supply’s (NASDAQ:TSCO) Q3 2026 sales top estimates
Rural goods retailer Tractor Supply (NASDAQ:TSCO) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 5.1% year on year to $3.91 b...
Via StockStory · October 22, 2026
Visteon (NASDAQ:VC) beats Q3 2026 sales expectations, full-year outlook slightly exceeds expectations
Automotive technology company Visteon (NYSE:VC) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 5.8% year on year to $970...
Via StockStory · October 22, 2026
Should You Forget ExxonMobil and Buy Cameco Stock Instead?fool.com
ExxonMobil and Cameco stock have gone in different directions this year. Here's why Cameco may be worth a look.
Via The Motley Fool · October 22, 2026
Lockheed Martin’s (NYSE:LMT) Q3 2026 sales beat estimates
Security and Aerospace company Lockheed Martin (NYSE:LMT) reported Q3 2026 results topping the market’s revenue expectations, with sales up 11.3% year on yea...
Via StockStory · October 22, 2026
4D Molecular Therapeutics Targets Wet AMD Injection Burden With 4D-150 Gene Therapymarketbeat.com
4D Molecular Therapeutics (NASDAQ:FDMT) used its first Investor Day to outline its development and commercial plans for 4D-150, an investigational intravitreal gene therapy for wet age-related macular degeneration, or wet AMD. Company executives and retina specialists described the therapy as a pote
Via MarketBeat · October 22, 2026
What Rentokil Initial (RTO) Said on Its Q3 Earnings Callmarketbeat.com
Rentokil Initial (NYSE:RTO) reported third-quarter revenue of $1.9 billion and organic growth of 3.4%, with Chief Executive Officer Mike Duffy describing the period as a “solid quarter” marked by progress on customer service, sales execution and business simplification.
North America generated 3.2%
Via MarketBeat · October 22, 2026
What Pearson (PSO) Said on Its Q3 Earnings Callmarketbeat.com
Pearson (NYSE:PSO) said third-quarter sales growth accelerated to 6%, supporting its full-year 2026 outlook as the education company announced a restructuring into four customer-led business units and narrowed its adjusted operating profit range.
Chief Executive Officer Omar Abbosh said the company
Via MarketBeat · October 22, 2026
Snap-on (NYSE:SNA) misses Q3 2026 revenue estimates, stock drops
Professional tools and equipment manufacturer Snap-on (NYSE:SNA) fell short of the market’s revenue expectations in Q3 2026, with sales flat year on year at ...
Via StockStory · October 22, 2026
3 AI Stocks That Could Split in 2027fool.com
These stocks all trade at share prices that could make a split attractive.
Via The Motley Fool · October 22, 2026
Here's How Much the Average 60-Year-Old Has Saved for Retirementfool.com
New Federal Reserve data shows what families in their late 50s and early 60s hold for retirement, why the average misleads, and how catch-up rules help.
Via The Motley Fool · October 22, 2026
Insteel’s (NYSE:IIIN) Q3 CY2026 sales beat estimates but stock drops
Steel wire manufacturer Insteel (NYSE:IIIN) reported calendar Q3 2026 (fiscal Q4 2026) results exceeding the market’s revenue expectations, with sales up 17....
Via StockStory · October 22, 2026
Prediction: This Is How Much SpaceX Stock Will Be Worth By the End of 2027fool.com
SpaceX stock is surging following a blowout third-quarter earnings report.
Via The Motley Fool · October 22, 2026
Amalgamated Financial (NASDAQ:AMAL) exceeds Q3 2026 expectations
Socially responsible bank Amalgamated Financial (NASDAQ:AMAL) beat Wall Street’s revenue expectations in Q3 2026, with sales up 17.7% year on year to $101.7 ...
Via StockStory · October 22, 2026
PulteGroup (NYSE:PHM) misses Q3 2026 revenue estimates, stock drops
Homebuilding company PulteGroup (NYSE:PHM) fell short of the market’s revenue expectations in Q3 2026, with sales falling 9.8% year on year to $3.97 billion....
Via StockStory · October 22, 2026
Is Capital One Financial a Buy After Its Latest Earnings Report?fool.com
Investors clearly thought so, as they snapped up the stock after the third-quarter figures were released.
Via The Motley Fool · October 22, 2026
Anthropic IPO: Here's What a $5,000 Investment Could Be Worth in 5 Yearsfool.com
Anthropic is growing rapidly, but over the long term, it will take more than top-line expansion to justify a $2 trillion IPO valuation.
Via The Motley Fool · October 22, 2026
Lazard (NYSE:LAZ) reports sales below analyst estimates in Q3 2026 earnings
Financial advisory firm Lazard (NYSE:LAZ) fell short of the market’s revenue expectations in Q3 2026, but sales rose 12.4% year on year to $814.2 million. It...
Via StockStory · October 22, 2026
1 ETF I'm Loading Up On Right Now -- Even if a Recession Is Comingfool.com
This ETF has been battle-tested and continues to thrive.
Via The Motley Fool · October 22, 2026